The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia "GLITTER"

Completed

Phase 4 Results N/A

Summary of Purpose

To date, there are no approved treatments for vascular cognitive impairment (VCI) and the main therapeutic efforts are aimed at controlling vascular risk factors for countering VCI development or progression. Several studies have reported cholinergic deficits in brain and cerebrospinal fluid of patients with VCI. The effect of choline alphoscerate in clinical studies of Alzheimer's disease and VCI improved...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 October 2013.

1 Nov 2010 29 May 2011 1 Mar 2013 1 Mar 2013 1 Oct 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts